A citation-based method for searching scientific literature

Daisuke Nonaka. Am J Surg Pathol 2012
Times Cited: 75







List of co-cited articles
618 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Justin A Bishop, Julie Teruya-Feldstein, William H Westra, Giuseppe Pelosi, William D Travis, Natasha Rekhtman. Mod Pathol 2012
236
70

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
William D Travis, Elisabeth Brambilla, Masayuki Noguchi, Andrew G Nicholson, Kim R Geisinger, Yasushi Yatabe, David G Beer, Charles A Powell, Gregory J Riely, Paul E Van Schil,[...]. J Thorac Oncol 2011
38


ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach.
Giuseppe Pelosi, Alessandra Fabbri, Fabrizio Bianchi, Patrick Maisonneuve, Giulio Rossi, Mattia Barbareschi, Paolo Graziano, Alberto Cavazza, Natasha Rekhtman, Ugo Pastorino,[...]. J Thorac Oncol 2012
92
32


Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation.
Luisella Righi, Paolo Graziano, Alessandro Fornari, Giulio Rossi, Mattia Barbareschi, Alberto Cavazza, Giuseppe Pelosi, Giorgio V Scagliotti, Mauro Papotti. Cancer 2011
98
25

AIS is an oncogene amplified in squamous cell carcinoma.
K Hibi, B Trink, M Patturajan, W H Westra, O L Caballero, D E Hill, E A Ratovitski, J Jen, D Sidransky. Proc Natl Acad Sci U S A 2000
410
20

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.
David H Johnson, Louis Fehrenbacher, William F Novotny, Roy S Herbst, John J Nemunaitis, David M Jablons, Corey J Langer, Russell F DeVore, Jacques Gaudreault, Lisa A Damico,[...]. J Clin Oncol 2004
18


Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.
William D Travis, Elisabeth Brambilla, Masayuki Noguchi, Andrew G Nicholson, Kim Geisinger, Yasushi Yatabe, Yuichi Ishikawa, Ignacio Wistuba, Douglas B Flieder, Wilbur Franklin,[...]. Arch Pathol Lab Med 2013
239
17

Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
Kyuichi Kadota, Jun-ichi Nitadori, Natasha Rekhtman, David R Jones, Prasad S Adusumilli, William D Travis. Am J Surg Pathol 2015
47
27

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
Manabu Soda, Young Lim Choi, Munehiro Enomoto, Shuji Takada, Yoshihiro Yamashita, Shunpei Ishikawa, Shin-ichiro Fujiwara, Hideki Watanabe, Kentaro Kurashina, Hisashi Hatanaka,[...]. Nature 2007
16

Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.
Natasha Rekhtman, Paul K Paik, Maria E Arcila, Laura J Tafe, Geoffrey R Oxnard, Andre L Moreira, William D Travis, Maureen F Zakowski, Mark G Kris, Marc Ladanyi. Clin Cancer Res 2012
261
14

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.
Jefferson Terry, Samuel Leung, Janessa Laskin, Kevin O Leslie, Allen M Gown, Diana N Ionescu. Am J Surg Pathol 2010
138
14

ROS1 rearrangements define a unique molecular class of lung cancers.
Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang,[...]. J Clin Oncol 2012
968
13


Comprehensive histologic analysis of ALK-rearranged lung carcinomas.
Akihiko Yoshida, Koji Tsuta, Harumi Nakamura, Takashi Kohno, Fumiaki Takahashi, Hisao Asamura, Ikuo Sekine, Masashi Fukayama, Tatsuhiro Shibata, Koh Furuta,[...]. Am J Surg Pathol 2011
206
12

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
Eunice L Kwak, Yung-Jue Bang, D Ross Camidge, Alice T Shaw, Benjamin Solomon, Robert G Maki, Sai-Hong I Ou, Bruce J Dezube, Pasi A Jänne, Daniel B Costa,[...]. N Engl J Med 2010
12

The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas.
Aydanur Kargi, Duygu Gurel, Burçin Tuna. Appl Immunohistochem Mol Morphol 2007
122
12

Significance of p63 amplification and overexpression in lung cancer development and prognosis.
Pierre P Massion, Peter M Taflan, S M Jamshedur Rahman, Pinar Yildiz, Yu Shyr, Mary E Edgerton, Matthew D Westfall, John R Roberts, Jennifer A Pietenpol, David P Carbone,[...]. Cancer Res 2003
242
12

P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
Beverly Y Wang, Joan Gil, David Kaufman, Li Gan, D Stave Kohtz, David E Burstein. Hum Pathol 2002
139
12



Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Andrew G Nicholson, David Gonzalez, Pallav Shah, Matthew J Pynegar, Manjiri Deshmukh, Alexandra Rice, Sanjay Popat. J Thorac Oncol 2010
150
10

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
Giorgio Vittorio Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, Ulrich Gatzemeier, Raghunadharao Digumarti, Mauro Zukin,[...]. J Clin Oncol 2008
10

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
Jonathan Weiss, Martin L Sos, Danila Seidel, Martin Peifer, Thomas Zander, Johannes M Heuckmann, Roland T Ullrich, Roopika Menon, Sebastian Maier, Alex Soltermann,[...]. Sci Transl Med 2010
590
10


p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
Giuseppe Pelosi, Felice Pasini, Catharina Olsen Stenholm, Ugo Pastorino, Patrick Maisonneuve, Angelica Sonzogni, Fausto Maffini, Giancarlo Pruneri, Filippo Fraggetta, Alessandra Cavallon,[...]. J Pathol 2002
118
10

p63 expression profiles in human normal and tumor tissues.
Charles J Di Como, Marshall J Urist, Irina Babayan, Marija Drobnjak, Cyrus V Hedvat, Julie Teruya-Feldstein, Kamal Pohar, Axel Hoos, Carlos Cordon-Cardo. Clin Cancer Res 2002
410
10

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
A Yang, M Kaghad, Y Wang, E Gillett, M D Fleming, V Dötsch, N C Andrews, D Caput, F McKeon. Mol Cell 1998
10

Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
Arne Warth, Thomas Muley, Esther Herpel, Michael Meister, Felix J F Herth, Peter Schirmacher, Wilko Weichert, Hans Hoffmann, Philipp A Schnabel. Histopathology 2012
75
10

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon,[...]. Science 2004
10

Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Eva Compérat, Fan Zhang, Cedric Perrotin, Thierry Molina, Pierre Magdeleinat, Beatrice Marmey, Jean-Francois Régnard, Josee Audouin, Saphie Camilleri-Broët. Mod Pathol 2005
111
10

Somatic mutations affect key pathways in lung adenocarcinoma.
Li Ding, Gad Getz, David A Wheeler, Elaine R Mardis, Michael D McLellan, Kristian Cibulskis, Carrie Sougnez, Heidi Greulich, Donna M Muzny, Margaret B Morgan,[...]. Nature 2008
10

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Giuseppe Pelosi, Giulio Rossi, Alberto Cavazza, Luisella Righi, Patrick Maisonneuve, Mattia Barbareschi, Paolo Graziano, Ugo Pastorino, Marina Garassino, Filippo de Braud,[...]. Int J Surg Pathol 2013
35
22

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. Arch Pathol Lab Med 2013
310
10

Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
Alan F Brown, Deepika Sirohi, Junya Fukuoka, Philip T Cagle, Maria Policarpio-Nicolas, David Tacha, Jaishree Jagirdar. Arch Pathol Lab Med 2013
39
20

Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.
Natasha Rekhtman, Laura J Tafe, Jamie E Chaft, Lu Wang, Maria E Arcila, Agnes Colanta, Andre L Moreira, Maureen F Zakowski, William D Travis, Camelia S Sima,[...]. Mod Pathol 2013
66
12

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.
Peh Sun Loo, Stuart C Thomas, Marianne C Nicolson, Margaret N Fyfe, Keith M Kerr. J Thorac Oncol 2010
156
9

Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
Diana N Ionescu, Diana Treaba, Cyril B Gilks, Samuel Leung, Daniel Renouf, Janessa Laskin, Richard Wood-Baker, Allen M Gown. Am J Surg Pathol 2007
92
9

Large cell carcinoma of the lung: an endangered species?
Javier Pardo, Ana M Martinez-Peñuela, Jesús J Sola, Angel Panizo, Alfonso Gúrpide, Jose M Martinez-Peñuela, Maria D Lozano. Appl Immunohistochem Mol Morphol 2009
40
17

Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.
Giuseppe Pelosi, Giulio Rossi, Fabrizio Bianchi, Patrick Maisonneuve, Domenico Galetta, Angelica Sonzogni, Giulia Veronesi, Lorenzo Spaggiari, Mauro Papotti, Mattia Barbareschi,[...]. J Thorac Oncol 2011
52
13

New driver mutations in non-small-cell lung cancer.
William Pao, Nicolas Girard. Lancet Oncol 2011
784
9

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.
Thomas J Lynch, Daphne W Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A Okimoto, Brian W Brannigan, Patricia L Harris, Sara M Haserlat, Jeffrey G Supko, Frank G Haluska,[...]. N Engl J Med 2004
9

Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.
Andres Matoso, Kamaljeet Singh, Rafik Jacob, Wesley O Greaves, Rosemarie Tavares, Lelia Noble, Murray B Resnick, Ronald A Delellis, Li J Wang. Appl Immunohistochem Mol Morphol 2010
109
9

A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma.
David Tacha, Charie Yu, Ryan Bremer, Weiman Qi, Thomas Haas. Appl Immunohistochem Mol Morphol 2012
21
33

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
Alice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, Subba R Digumarthy, Daniel B Costa, Rebecca S Heist, Benjamin Solomon, Hannah Stubbs, Sonal Admane, Ultan McDermott,[...]. J Clin Oncol 2009
9

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
9

Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung.
Valentina Monica, Paolo Ceppi, Luisella Righi, Veronica Tavaglione, Marco Volante, Giuseppe Pelosi, Giorgio V Scagliotti, Mauro Papotti. Mod Pathol 2009
79
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.